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Cholinergic neurons, which express choline acetyltransferase (ChAT), are a major neuron subset generated in the basal forebrain. Areas
presumed to be sites of origin of cholinergic neurons are roughly demarcated by expression of Olig2, a basic helix–loop–helix transcription factor,
which includes the medial ganglionic eminence, septal area, and anterior entopeduncular/preoptic area. In the present study, we examined the
involvement of Olig2 in cholinergic differentiation. When the Olig2-expressing cells at E12.5 were permanently modified to express the lacZ or
EGFP gene by tamoxifen-induced Cre-mediated recombination, the cells marked by reporter gene expression were widely distributed in the basal
forebrain by E18.5, some of which expressed neuronal markers. We showed that a small number of cells were double-positive for ChAT and X-gal
or EGFP in almost all cases. In addition, the number of ChAT+ cells was reduced to 60% in the Olig2 knockout mouse basal forebrain. No
evidence of elevated apoptosis or reduced proliferation was observed in the knockout mouse forebrain. The present study provides the first direct
evidence for involvement of the Olig2 gene in cholinergic differentiation in the basal forebrain.
© 2006 Elsevier Inc. All rights reserved.Keywords: Tamoxifen; Cre-mediated recombination; LacZ; EGFP; Choline acetyltransferase; In situ hybridization; BrdU; Lhx8Introduction
Cholinergic neurons are one of the major neuron subsets in
the mammalian central nervous system (CNS). They are roughly
divided into 5 cell groups based on their localization: (1) the
striatum (caudate–putamen; CP), (2) the basal nuclear complex,
(3) the pontine tegmentum, (4) the cranial motor nuclei, and (5)
the spinal cord (Armstrong et al., 1983). Cholinergic neurons are
identified by their expression of choline acetyltransferase⁎ Corresponding author. Division of Neurobiology and Bioinformatics,
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doi:10.1016/j.ydbio.2006.01.031(ChAT), which is the rate-limiting enzyme in acetylcholine
synthesis. ChAT-positive (ChAT+) neurons in the telencephalon
are involved in sensory-motor integration and recognition, and
are restricted to the basal forebrain (Mufson et al., 2003).
Cholinergic neurons in the CP are local circuit interneurons,
while those in the basal nuclear complex are projection neurons,
providing the majority of the functional cholinergic innervation
of the cerebral cortex (Butcher, 1995; Woolf et al., 1984).
Cholinergic neuron dysfunction in the basal forebrain results in
severe motor and cognitive defects, such as Alzheimer's disease
(Mufson et al., 2003).
Because of the structural complexity in the basal forebrain,
the development of cholinergic neurons has remained largely
unknown. Recently, cholinergic neurons in the basal forebrain
were reported to originate mainly from the medial ganglionic
eminence (MGE), and to a lesser extent from the lateral
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from the ventromedial parts of the ventricular zone (VZ) of the
anterior lateral ventricle that involves the septal area and
anterior entopeduncular/preoptic area (AEP/POA) (Marín and
Rubenstein, 2002; Zhao et al., 2003; Mori et al., 2004).
Although transcriptional regulation of subpallial neuron
development has been studied extensively (Marín et al.,
2000), the mechanisms regulating cholinergic neuron differen-
tiation are not fully uncovered. We focused on the Olig2 gene in
the present study.
The Olig2 gene is one of the major transcription factors
expressed in the VZ of the MGE and in the AEP/POA, both of
which are regarded as origins of cholinergic neurons. Olig2 is
necessary for the differentiation of oligodendrocytes and motor
neurons that express ChAT (Mizuguchi et al., 2001; Novitch et
al., 2001; Takebayashi et al., 2002). In addition, cholinergic
neurons in the hindbrain are partially affected by the double
deficiency of Olig2 and Olig1 genes (Zhou and Anderson,
2002). Therefore, the Olig2 gene regulates the differentiation of
cholinergic neurons, at least in the hindbrain and spinal cord.
Here we demonstrate that Olig2 regulates cholinergic neuron
development in the basal forebrain. At least a certain fraction of
Olig2-expressing cells differentiate into ChAT+ neurons and a
lack of the Olig2 gene decreases the number of cholinergic
neurons in the basal forebrain, especially in the CP. These data
suggest that Olig2 is involved in the development of
telencephalic cholinergic neurons.
Materials and methods
Mice
Olig2KICreER mice and CAG-CAT-Z, and Z/EG reporter mice have been
previously described (Novak et al., 2000; Sakai and Miyazaki, 1997;
Takebayashi et al., 2002). Olig2KICreER heterozygous mice are phenotypically
normal. Olig2KICreER/CAG-CAT-Z or Olig2KICreER/Z/EG double-heterozygous
males were crossed to wild type C57BL/6J females (Japan SLC Inc. Shizuoka,
Japan) to obtain Olig2KICreER/CAG-CAT-Z or Olig2KICreER/Z/EG embryos.
Olig2KICreER heterozygous mice were mated to generate Olig2 knockout mice.
Midday of the plugged day was termed embryonic day (E) 0.5. Some dams
received an intraperitoneal injection of 5-bromo-2′-deoxyuridine (BrdU, 25 mg/
kg; Sigma-Aldrich, St. Louis, MO) 1 h before sacrifice. All animal procedures
were conducted in accordance with guidelines described by the National
Institutes of Health Guide for Care and Use of Laboratory Animals, and
approved by the Animal Research Committee of the National Institute for
Physiological Sciences.
Genotyping
Genotypes were determined by polymerase chain reaction (PCR) as
described previously (Novak et al., 2000; Sakai and Miyazaki, 1997;
Takebayashi et al., 2002).
Tamoxifen treatment
To activate CreER™, pregnant females were injected intraperitoneally with
1.5 mg 4-hydroxytamoxifen (4-OHT; Sigma) that had been dissolved in a
DMSO/ethanol/sesame oil (4:6:90) mixture at a concentration of 10 mg/ml
(Robinson et al., 1991; Danielian et al., 1998). The injections were performed
between 8 a.m. and noon at E9.5, E12.5, or E14.5 and embryos were analyzed at
E11.5, E14.5, or E18.5. Some of 4-OHT-treated dams were delivered of pups
which grew to adulthood (6 weeks or older).Histology
Histologic analyses were performed using frozen cryostat sections, free-
floating sections, and paraffin sections. Dams were deeply anesthetized with
diethyl ether, and pups were removed from the uterus at stages from E9.5 to
E18.5. Adult mice received an intraperitoneal injection of pentobarbital (50 mg/
kg body weight).
For cryostat and free-floating sections, brains were fixed by immersion
(E9.5–E14.5), or by transcardial perfusion (E15.5 or older) with 4%
paraformaldehyde in phosphate buffered saline (PBS). They were immersed
in the same fixative at 4°C overnight and then transferred to a solution of 20%
sucrose in PBS for cryoprotection at 4°C overnight. Tissues from E18.5 or adult
animals were cut at 70 μm with a tissue slicer (Microslicer DSK-3000, Dosaka,
Kyoto, Japan), or at 40 μm with a frozen microtome. The tissues of younger
animals were cut at 18 μm with a cryostat (CM3050; Leica, Bensheim,
Germany), thaw-mounted onto MAS coated glass-slides (Matsunami Glass,
Osaka, Japan), and stored at −80°C until use.
For paraffin sections, brains were fixed with Bodian-II fixative (70%
ethanol, 5% formalin, and 5% acetic acid) overnight and embedded in paraffin
after dehydration with a graded ethanol series and cleared with xylene. Sections
(6 μm or 10 μm) were cut with a microtome, collected on MAS-coated glass
slides, and stored at room temperature until use. The paraffin sections were
dewaxed and rehydrated before staining.
Gross morphology of brains from E18.5 mice was observed after fixation
and compared between Olig2 knockout and wild/heterozygous animals. The
brains were weighed, and longitudinal and transverse length of the cerebral
cortex was measured under a dissection microscope (Olympus SZX12).
X-gal staining
LacZ expression was determined in the Olig2KICreER/CAG-CAT-Z, which
had been treated with 4-OHT, by X-gal (5-bromo-4-chloro-3-indolyl-β-D-
galactoside) staining (Leone et al., 2003; Ding et al., 2005) with minor
modifications. Cryostat or free-floating sections were washed 3 times for 5 min
in PBS and incubated for 24 h with X-gal staining solution (5 mMK4[Fe(CN)6],
5 mM K3[Fe(CN)6], 20 mM Tris–HCl (pH7.3), 2 mM MgCl2, and 0.1% X-gal
in PBS) at room temperature. Sections were then washed once for 5 min in PBS.
The free-floating sections were mounted onto gelatin-coated glass slides and
dried in air. They were further subjected to in situ hybridization (ISH) or
immunohistochemistry (IHC), or coverslipped after counterstaining with
nuclear fast red, neutral red or NeuroTrace (Molecular Probes, Eugene, OR,
USA).
In situ hybridization
The method for ISH on cryostat sections was previously described (Ding et
al., 2005). The following cDNAs were used as probes: mouse Olig2
(Takebayashi et al., 2000), mouse ChAT (GenBank accession number:
NM_009891, nt 300–2611), mouse GAD65 (a gift from Dr. Yuchio Yanagawa;
Makinae et al., 2000), Mash1 (a gift from Dr. David Anderson), mouse Lhx8
(GenBank accession number:XM_131238, nt 264–1564), and mouse Nkx2.1
(GenBank accession number:NM_009385, nt 1–1119). ChAT, Lhx8, and
Nkx2.1 cDNAs were cloned by reverse transcription-PCR (RT-PCR). Some of
sections were processed with immunohistochemistry after ISH.
Immunohistochemistry
Sections on glass slides were treated with heat in citrate buffer (10 mM, pH
6.0) at 95°C for 5 min. Then, sections on glass slides and free-floating sections
were treated with 0.1% hydrogen peroxide in PBS containing 0.1% Triton X-
100 (PBST) for 30 min to block endogenous peroxidase. After incubation with
5% normal goat serum, the sections were incubated with primary antibodies (see
below) overnight. The sections were washed with PBST 4 times, and then
incubated with a species-specific secondary antibody conjugated to biotin
(1:200; Vector Laboratories, Burlingame, CA, USA) for the ABC method or to
Alexa 488 or 594 (Molecular Probes) for fluorescent detection for 60 min. For
the ABC method, the sections were then incubated with avidin–biotin–
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at room temperature. Immune complexes were visualized by immersion of
sections in 0.05% diaminobenzidine/0.015% H2O2. For double immunofluo-
rescent staining, species-specific secondary antibodies conjugated to Alexa
Flour 488 or 594 (1:1000; Molecular Probes) were used to visualize the antigen
localization. Nuclei of cells were counterstained with Hoechst33342 (0.1 μg/ml,
10 min).
The primary antibodies used were mouse anti-NeuN (1:2000; Chemicon,
Temecula, CA), mouse anti-MAP2 (1:200; Sigma), mouse anti-class III tubulin
(Tuj-1, 1:2000; BAbCo, Richmond, CA), mouse anti-BrdU (1:3000; BD
Bioscience Pharmingen, San Diego, CA), mouse anti-cleaved caspase-3 (1:500;
Cell Signaling Technology, Beverly, MA), rabbit anti-GFP (1:1000; Molecular
Probes), rat anti-GFP (1:500; Nacalai Tesque, Kyoto, Japan), rabbit anti-ChAT
(1:500; Chemicon), and rabbit anti-Olig2 (1:500; IBL, Tokyo, Japan).
Quantitative analyses
The number or density of ChAT- or activated caspase3- labeled cells was
determined and compared for the brains of wild/heterozygote controls and
knockouts. Since the number of ChAT-mRNA-containing cells varied among the
experiments, we stained the basal forebrain of the wild/heterozygote and
knockout mice simultaneously and compared them. Each result was expressed
as a ratio (Fig. 4). BrdU-positive cell density was determined by enumerating the
labeled cell number in the unit area (150 μm × 110 μm) of the VZ in the medial
ganglionic eminence and septal area of wild type, heterozygous and homo
knockout mice. Olig2/Lhx8 double-positive cells were counted in the border
area of the unit area (150 μm × 110 μm) between the ventricular zone and mantle
layer of the E13.5 MGE and POA/AEP. In general, at least three animals were
used for quantitative analysis.
The atlases of the fetal and adult mouse brain were used to identify brain
structures (Schambra et al., 1992; Franklin and Paxinos, 1997), and terminology
followed that by Marín and Rubenstein (2002) as well as these atlases.
Results
Distribution and neuronal differentiation of Olig2 lineage cells
in the basal forebrain
We first examined the localization and distribution of
Olig2-expressing cells and their cohorts in the basal forebrain.
Olig2-mRNA was detected in the basal forebrain by E9.5, and
Olig2 expression was mainly observed in the diencephalon,
likely the ventral thalamus (Takebayashi et al., 2000), and
weak signals were detected in the telencephalon (Fig. 1A).
The basal forebrain differentiated into roughly three subdivi-
sions by E12.5, namely the LGE, MGE, and the AEP/POA.
Olig2 was expressed intensely in the MGE and AEP/POA,
and weakly in the LGE (Fig. 1B; Takebayashi et al., 2000).
Olig2 expression continued in the zona limitance intrathala-Fig. 1. Distribution of Olig2-expressing cells and their progeny in the forebrain.
hybridization on coronal sections of wild type mice at E9.5 (A) and E12.5 (B).Olig2-
very weak signals in the telencephalon (Tel). The asterisk indicates the basal telenceph
localized in the medial ganglionic eminence (MGE), anterior entopeduncular area (AE
forebrain of Olig2KICreER/CAG-CAT-Z mouse following 4-OHT administration at E
recombination and was inherited by the progeny of Olig2-expressing VZ cells. Each d
small to show in a lower magnification, the labeled cells are demonstrated by artificial
at E9.5. On the other hand, a large number of X-gal+ cells were in the basal forebrain
and basal magnocellular complex, including the magnocellular preoptic nucleus (Mg
panel D represents an X-gal-labeled cell. The labeled cell was counter-stained with
nucleolus. (G–I) EGFP expression following Cre-mediated recombination in an Olig
NeuN positive (arrow in panel H), indicative of neuronal differentiation of Olig2 lin
septum. Th, thalamus. 3V, third ventricle. Scale bars in panel A = 50 μm, in panelsmica of the diencephalon (not shown). Cells expressing Olig2-
mRNA gradually spread throughout the forebrain from the
ventral part to the cerebral cortex as embryo developed (not
shown).
Since recent evidence strongly suggested that the cholin-
ergic neurons in the basal forebrain are derivatives of the
MGE, septal area and AEP/POA, we performed lineage
tracing experiment of Olig2+ progenitors in these areas using
tamoxifen-induced Cre-mediated recombination (CreER/loxP
system). When Olig2KICreER/CAG-CAT-Z or Olig2KICreER/Z/
EG double-heterozygous embryos were treated with 4-OHT
through an intraperitoneal injection into pregnant mothers,
some cells expressing Olig2 underwent Cre-mediated recom-
bination, resulting in expression of LacZ in Olig2KICreER/
CAG-CAT-Z or EGFP in Olig2KICreER/Z/EG mice, which was
inherited by their cohorts. When 4-OHT was injected into the
dams at E9.5, their E18.5 offspring contained X-gal+ cells
mainly in the diencephalons, such as in the ventral thalamus
(not shown) and to a much lesser extent in the telencephalon
(Figs. 1C, E). The results were expected from the fact that
very weak Olig2 expression was observed in the E9.5
telencephalon (Fig. 1A). In contrast, when dams were
injected with 4-OHT at E12.5 and their offspring were
analyzed at E18.5, X-gal+ cells were widely distributed in the
telencephalon (Figs. 1D, F), as well as in the diencephalon
(Fig. 1F). The X-gal+ cells following 4-OHT injection at
E12.5 were observed in the diagonal band (DB), caudal part
of the CP, globus pallidus (GP), substantia innominata (SI),
magnocellular preoptic area (MgPO), and less frequently in
the cerebral cortex and the hippocampus. Therefore, the
progenies of Olig2-expressing cells at E12.5 migrate
throughout the telencephalon, a conclusion that is consistent
with other reports that the progeny from the basal forebrain
actively migrates throughout the telencephalon (Anderson et
al., 1997; Tamamaki et al., 1997; Nery et al., 2001; Tekki-
Kessaris et al., 2001).
X-gal reaction products showed small round precipitates in
the cells stained with neutral red, which exhibits characteristics
of neuron such as involvement of Nissl substances and a pale
nucleus with darkly-stained nucleolus (inset in Fig. 1D).
Neuronal characters in some of the Olig2 lineage cells were
further confirmed in the adult double heterozygous mice by
double-labeling with reporter molecules and neuronal markers
such as NeuN (Figs. 1G–I), Tuj-1, MAP2 and NeuroTrace(A and B) Distribution of Olig2-mRNA in the forebrain, detected by in situ
mRNA in the E9.5 forebrain is primarily observed in the diencephalon (Die), and
alon, a future ganglionic eminence. In the E12.5 basal forebrain,Olig2-mRNA is
P), and septal VZ (not shown). (C–F) X-gal+ cell distribution in the E18.5 basal
9.5 (C, E) or at E12.5 (D, F). LacZ expression was induced by Cre-mediated
ot indicates a labeled cell. Since X-gal reaction products (inset in panel D) are too
dots. Few LacZ+ cells were found in the basal forebrain following administration
, such as the caudate–putamen (CP), globus pallidus (GP), diagonal band (DB)
PO) and substantia innominata (SI), as well as in the cerebral cortex. The inset in
neutral red, which shows Nissl substance and pale nucleus with darkly stained
2 lineage cell in the Olig2KICreER/Z/EG mouse. The EGFP-expressing cell (G) is
eage cell. (I) A merged picture. Hipp, hippocampus. LV, lateral ventricle. Sep,
B–F = 500 μm, in panels G–I = 20 μm, in inset = 10 μm.
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been induced by Cre-mediated recombination at fetal stages,
were still observed in the adult stages (Figs. 1G and 2D).Immunoreactivities of neuronal markers (Fig. 1H) were
localized in the EGFP- (Figs. 1G, I) or X-gal-positive perikar-
yon (not shown).
Fig. 2. Differentiation of Olig2 lineage cells into cholinergic neuron. (A and B) The basal forebrain of E18.5 Olig2/CAT-CAT-Z double heterozygous mice treated with
4-OHT on E12.5. The forebrain is subjected to X-gal histochemistry, followed by ChAT ISH. Black dots indicated by arrowheads are double labeled cells in the
magnocellular preoptic nucleus (MgPO) (A) and diagonal band (DB) (B). Insets show higher magnification picture of the double-labeled cells (arrows). (C–F)
Anterior part of the cerebrum of 6-month-old Olig2/Z/EG double heterozygous mouse treated with 4-OHT at E12.5. The section is double immunostained with anti-
EGFP and with anti-ChATantibodies, and counterstained with Hoechst33342. Ayellow dot indicated by an arrowhead indicates a double-labeled cell that is magnified
in panels D–F. CCx, cerebral cortex. CP, caudate–putamen. DB, diagonal band. MgPO, magnocellular preo0.ptic nucleus. Scale bars in panels A–C = 500 μm; inset of
panels A and B = 20 μm; F = 50 μm.
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neuron
Since some of the above-mentioned structures are known to
contain cholinergic neurons and a certain fraction ofOlig2 lineage
cells differentiate into neurons (Fig. 1), we next examined
whether cohorts of the Olig2-expressing cells differentiate into
cholinergic neuron. To directly demonstrate this, we examined
whether Olig2 lineage cells, which expressed reporter molecule
such as LacZ in Olig2KICreER/CAG-CAT-Z or EGFP in
Olig2KICreER/Z/EG mice by Cre-mediated recombination,
expressed a cholinergic neuron marker ChAT (Fig. 2). Since, as
shown in Fig. 1, 4-OHT treatment at E12.5 results inmore labeled
cells in the telencephalon as compared to that at E9.5, we mainly
examined the E18.5 or adult forebrain of the double-heterozygous
animals treated with 4-OHT at E12.5. In the Olig2KICreER/CAG-
CAT-Z heterozygous animals at E18.5, X-gal-positive cells,
which underwent recombination, were widely distributed in the
basal forebrain.When these specimens were subsequently treated
with ChAT ISH, a limited fraction of recombined cells revealed
ChAT-mRNA expression; in well-recombined cases, approxi-
mately 5% of X-gal labeled cells expressed ChAT-mRNA,
especially in the DB and in the MgPO (Figs. 2A, B). In
Olig2KICreER/Z/EG double-heterozygotes in adult stages (3–12months old), Olig2 lineage cells with EGFP expression were
much less as compared to X-gal-positive cells in the E18.5
Olig2KICreER/CAG-CAT-Z. In spite of this, a limited number of
the EGFP-expressing cells showedChATimmunoreactivity in the
basal forebrain (Figs. 2C–F). Content of the LacZ- or EGFP-
positive Olig2 lineage cell number and of the double-labeled cell
number varied among individual animals. This is probably due to
the variable and low efficiency of Cre-mediated recombination
(Masahira, Takebayashi and Ikenaka, submitted for publication).
In spite of the low frequency of double-positive cell appearance, it
should be emphasized that 14 out of 15 mice that had been
injected with 4-OHT at E12.5 contained cells in which Olig2-
CreER™-mediated recombination had occurred with a choliner-
gic character in the E18.5 or adult basal forebrain.
Decrease in the cholinergic neuron number in the Olig2
knockout basal forebrain
The results above clearly demonstrate that at least a certain
fraction of Olig2+ cells in the E12.5 basal forebrain differentiate
into cholinergic neurons. To elucidate whether the Olig2 func-
tions in cholinergic differentiation, the appearance ofChAT+ cells
was examined in the basal forebrain of the Olig2-deficient mouse.
We usedE14.5 andE18.5mice, becauseChAT-mRNAexpression
Fig. 3. Reduced number of ChAT+ cells in the basal forebrain of the Olig2-deficient mouse. ChAT ISH. (A and C) Wild type mouse. (B and D) Olig2 knockout mouse.
(A and B) E14.5. (C and D) E18.5. Each dot indicates a ChAT-mRNA-expressing cell. Since signals in E14.5 brain are too weak to show in a lower magnification, the
labeled cells are demonstrated by artificial dots. Higher magnification of real signals pointed by arrowheads is shown in insets. Although ChAT+ cells were distributed
in similar areas between the wild type mouse and Olig2-deficient mouse, the number and density of the labeled cells is much less in the knockout mouse than in the
wild type mouse. CP, caudate–putamen. LGE, lateral ganglionic eminence. MgPO, magnocellular preoptic area. 3V, third ventricle. Scale bars in panel D = 500 μm;
and in inset = 100 μm.
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available as Olig2 knockout mice are stillborn (Lu et al., 2002;
Takebayashi et al., 2002). We carried out three independent ISH
experiments with 3 knockout and 3 wild/heterozygote animals at
E14.5 and four experiments with 5 knockout and 7 wild/hetero-
zygote animals at E18.5. In the E14.5 basal forebrain, ChAT+
cells were observed in the mantle layer underneath the
subventricular zone (SVZ) of the MGE and AEP/POA in both
wild/heterozygote control andOlig2 knockoutmice (Figs. 3A,B).
The number of cholinergic neurons was reduced in the knockoutFig. 4. Comparison of the ChAT+ cell number between wild/heterozygote control and
cell number in Olig2 knockout mouse forebrain. Both the Olig2-deficient and the c
number of labeled cells in the Olig2 knockout mouse was compared to that in the contr
the total ChAT+ cell number was reduced up to 60% in the Olig2-deficient mouse. (B)
anterior and posterior parts of the basal magnocellular complex (BMCa and BMCp, r
were shown as marks (Expl-1 to -4), and the average as short horizontal bars. CP an
mouse while GP and BMCa show individual variation. In three experiments (Exp
experiment, while the remaining one experiment (*Expl-4) was carried out with 2 kbasal forebrain (Fig. 3B). The distribution of ChAT+ cells in the
E18.5 basal forebrain was also similar between wild/heterozygote
control animals and Olig2-deficient mice (Figs. 3C, D). However,
as observed in E14.5 mice, ChAT+ cells were sparse in knockout
mice than in controls, and thus, the labeled cell number was lesser
in Olig2 knockout mice than in control animals (Fig. 3D). The
number of labeled cells was determined and compared between
the two groups. In both the E14.5 and E18.5 basal forebrain, the
total number of ChAT+ cells was reduced to approximately 60%
in the Olig2 knockout basal forebrain (Fig. 4A).Olig2-deficient basal forebrain at E14.5 and E18.5. (A) Reduction of the ChAT+
ontrol forebrain sections were simultaneously subjected to ChAT ISH, and the
ol mouse. The ratio of cell number was expressed as a percentage. In both stages,
The ChAT+ cell number of the caudate–putamen (CP), globus pallidus (GP), and
espectively) was compared as in Fig. 4. Results of four independent experiments
d BMCp contain a lesser number of ChAT-positive cells in the Olig2 deficient
l-1 to -3), one knockout and one wild/heterozygous mice were used in each
nockout brains and 3. wild/heterozygous brains.
Fig. 5. Proliferation of cells in the VZ of medial ganglionic eminence and septal
area at E12.5. (A) VZ of the medial ganglionic eminence (MGE). (B) VZ of the
septal area. Location of the areas is referred to as in Figs. 1 and 6. BrdU-labeled
cell number in the unit area (150 μm × 110 μm) was almost identical among wild
type (WT; n = 3), Olig2 heterozygous (Het; n = 3) and Olig2 knockout mouse
(KO; n = 3) in both areas.
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ChAT+ cell number between knockout and wild/heterozygote
control mice at E18.5. Since, in the perinatal mouse forebrain,
neurons in these areas have not yet achieved full morphological
differentiation, the borders of the subdivisions are not clear.
Thus, the basal forebrain was roughly divided into 4 subdi-
visions for convenience: (1) the CP, including the nucleus
accumbens, (2) the rostral part of the basal magnocellular nuclei
(BMCa), including the DB and medial septal nucleus, (3) the
GP, and (4) the caudal part of the basal magnocellular nuclei
(BMCp) that included MgPO, SI, and basal nucleus. As shown
in Fig. 4B, CP and BMCp contained reduced number of ChAT+
cells in the Olig2 knockout mouse, while GP and BMCa did not
show obvious reduction of the ChAT+ cell number. Despite the
regional variation in the reduction of cholinergic neuron
number, it is strongly suggested that Olig2 plays some roles
in the differentiation of cholinergic neurons in the basal
forebrain, especially CP and BMCp.
No elevated apoptosis or reduced proliferation in the
Olig2-deficient mouse
To verify whether apoptosis or reduced cell proliferation was
involved in the reduction of the ChAT+ cell number in Olig2-
deficient mouse, immunocytochemistry with anti-activated
caspase 3 and BrdU incorporation assays were carried out.
Activated caspase 3 is a marker for apoptosis (Di Cunto et al.,
2000), and BrdU is incorporated by cells in the S-phase of the
cell cycle and thus is indicative of proliferation. Few or no
activated caspase 3 labeled cells were found in the E14.5 basal
forebrain where ChAT+ cells were residing in both the wild/
heterozygote control and Olig2 knockout mice. In addition,
pyknotic cells, exhibited with Hoechst or hematoxylin staining,
were rarely detected in the basal forebrain at this stage.
Therefore, accelerated apoptosis was not likely to be the cause
of the decrease in the ChAT+ cell number in the Olig2-deficient
basal forebrain.
Cell proliferation was also examined in the VZ of the MGE
and of the septal region. BrdU incorporation was analyzed 1 h
after administration of BrdU into dams. The number of labeled
cells per unit area was almost identical in the VZ of the MGE
and of the septal area, among three genotypes, namely wild
type, Olig2 heterozygote and Olig2 homozygous knockout
(Fig. 5). Thus, a reduction in cell proliferation was unlikely to
be the cause of the decrease in the ChAT+ cell number in the
knockout mouse.
Expression of Lhx8 in the Olig2 lineage cells
The above results strongly suggest that Olig2 deficiency
affects the differentiation of the ChAT+ cells. Several
transcription factors, such as Nkx2.1, Mash1 (Marín et al.,
2000) and Lhx8 (Asbreuk et al., 2002; Zhao et al., 2003; Mori et
al., 2004), have been reported to be involved in the
differentiation of telencephalic cholinergic neurons. We studied
whether expression of these factors is affected in the Olig2
deficient mouse, however, expression of none of them wasaffected in the basal forebrain at E12.5 (data not shown for
Nkx2.1 and Mash1, Figs. 6A, B for Lhx8). Lhx8-independent
pathway in the generation of cholinergic neurons has been
suggested by Zhao et al. (2003), as in the Lhx8 deficient
forebrain the cholinergic neuron number was reduced dramat-
ically in the CP while that in the ventral striatum seemed to be
normal. Since only 40% reduction in the number of cholinergic
neurons were observed in the Olig2 knockout, we examined the
expression pattern of Olig2 and Lhx8 more precisely. While
Olig2 was expressed in the ventricular zone of the ganglionic
eminence in the E12.5 basal forebrain (Fig. 1B), Lhx8-mRNA
was mainly distributed in the SVZ and mantle layers of the
MGE, septal area and POE/AEP at the same stage (Fig. 6A).
Only a limited number of the ventricular cells expressed Lhx8
(not shown). The LGE was devoid of Lhx8 expression at this
stage. This discrete expression pattern of two transcription
factors continued in the E13.5 basal forebrain (Fig. 6C). Figs.
6C–E shows double staining of Olig2 immunoreactive cells
(brown) and Lhx8-mRNA-expressing cells (purple). Under
closer examination, Olig2-positive cells were partially inter-
mingled with Lhx8-expressing cells in the border area between
ventricular zone and the SVZ, and less than 10% of Lhx8-
expressing cells were double-labeled with Olig2 in this region
(8.52 ± 4.35% in the MGE and 5.40 ± 2.93% in the septum/
POA/AEP; Figs. 6D, E). By contrast, none of cells co-expressed
Olig2 and Lhx8 in the mantle layer at these stages (not shown).
Expression patterns of Olig2 and Lhx8 in the E15.5 forebrain
were essentially similar to those in E13.5, though double-
positive cells were much less even though more Olig2-positive
cells had been distributed in the mantle layer by E15.5 (not
shown).
This discrete but spatially-continuous expression suggested
that cells in these regions would express Olig2 in the ventricular
zone, cease Olig2 expression when they leave the ventricular
zone and subsequently express Lhx8 in the SVZ and mantle
layers. To directly elucidate this possibility, we again used
Olig2KICreER/CAG-CAT-Z mice that had been treated with 4-
Fig. 6. Expression of Lhx8 in the Olig2 lineage cell. (A andB) Lhx8 expression in the E12.5 basal forebrain of Olig2 heterozygous (A) andOlig2 deficient (B)mice. Note
that most of Lhx8-expressing cells are located in the subventricular (SVZ) andmantle (ML) layers of theMGE and septal area, but not in the LGE.No obvious difference
is noticed between the two. (C) Double labeling of a section with Lhx8 ISH (purple) and with Olig2 IHC (brown). Areas pointed by arrowheads D and E are magnified in
D and E, respectively. Note that Lhx8 expression is not found in the LGE. (D and E) Higher magnification pictures of the transitional zone from the ventricular zone (VZ)
to SVZ in the MGE (D) and AEP (E). Arrows indicate double-labeled cells. (F) Forebrain of the E18.5 Olig2KICreER/CAG-CAT-Z double heterozygous mouse that had
been treated with 4-OHT at E12.5. The section is treated with X-gal histochemistry, followed by Lhx8 ISH. Boxed areas are magnified in panels F and G, respectively.
Note that Lhx8 signal is very dense in the GP and BMCp, while that in the CP is sparse. (G) Higher magnification of the boxed area in the CP. No X-gal-positive LacZ-
expressing cells express Lhx8. Arrowheads indicate X-gal-positive Olig2 lineage cells. (H) Higher magnification of the boxed area in the GP. Arrows indicate X-gal-
positive Olig2 lineage cells with Lhx8 expression. Scale bars in panels A–C, F = 500 μm; in panels D and E = 20 μm; in panels G and H = 50 μm.
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heterozygous mice was subjected to X-gal histochemistry,
followed by Lhx8 ISH at E18.5. Overlapping distribution of X-
gal-positive cells and Lhx8-expressing cells was observed in the
basal forebrain. Under closer examination, approximately a half
of X-gal-positive cells in the DB, MgPO (Figs. 6F, H) and GP
expressed Lhx8 intensely while in the CP few cells were double
positive for X-gal and Lhx8 (Figs. 6F, G). These results
demonstrate that at least some portions of Lhx8-positive cells
are derived from Olig2-expressing cells after down regulation of
the Olig2 expression.
Discussion
Olig2 lineage cells generate cholinergic neurons in the basal
forebrain
Cholinergic neurons in the telencephalon are restricted to the
basal forebrain but are not observed in the cortex (or pallium).
Therefore, the VZ of the basal forebrain can be regarded as the
main source of subpallial cholinergic neurons. The subpallial
VZ in the developing telencephalon belongs to roughly four
subdivided regions: the MGE, LGE, AEP/POA, and septum.
Olsson et al. (1998) demonstrated that transplantation of thefetal MGE into the adult CP generated a considerable number of
ChAT+ cells within the grafted tissues, while that of the LGE
did few, suggesting that MGE is a main origin of subpallial
cholinergic neurons. More recently, cholinergic neuron defects
were revealed in the basal forebrain of several knockout mouse
lines that are devoid of transcription factors expressed in the
basal forebrain. Therefore, the expression sites of some of these
transcription factors were regarded as cholinergic origins. Taken
together, these results indicated that subpallial cholinergic
neurons are derived from the MGE, AEP/POA, and septal VZ
(Marín et al., 2000; Zhao et al., 2003; Mori et al., 2004).
Among the various kinds of transcription factors expressed
in the subpallial VZ, Olig2 expression was consistent with the
site of origin of telencephalic cholinergic neurons. The
majority, if not all, of the VZ cells in these regions expressed
Olig2 at E12.5. Indeed, tamoxifen-induced Cre-mediated
recombination at around E12.5 resulted in the expression of
LacZ in the basal forebrain, and some of the ChAT+ cells
also expressed reporter molecules, although the percentage of
ChAT+/X-gal+ or ChAT+/EGFP+ double-positive cells among
recombined cells was approximately 5%, or less. The efficiency
of tamoxifen-induced recombination varied among individuals;
maximal value may be 10% while, in lower recombined cases,
less than 1% of the Olig2-expressing cells expressed LacZ or
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publication). Therefore, the low frequency of double-labeled
cells was probably due to the low efficiency of Cre-mediated
recombination. In addition, it was relatively difficult to obtain
intense ChAT-mRNA signals after X-gal staining. In spite of
such low frequencies, we emphasize that in almost all cases (14/
15, 93%) double heterozygous animals that had received a 4-
OHT injection at E12.5 contained Olig2 lineage cholinergic
neurons. Therefore, the present results provided a direct
evidence for the differentiation of a certain portion of Olig2
lineage cells into cholinergic neurons in the basal forebrain.
Olig2 regulates cholinergic neuron development
In general, establishment of domain structure and develop-
ment of specific cell type in the embryonic CNS is regulated by
bHLH and homeobox transcription factors (Tanabe and Jessell,
1996). Olig2 is reported to have a role in establishing the pMN
domain, which gives rise to motor neurons and oligodendrocyte
precursor cells (OPCs) in the spinal cord (Lu et al., 2002; Zhou
and Anderson, 2002; Takebayashi et al., 2002). Cholinergic
neurons in the spinal cord were severely affected by the loss of
Olig2, and hypoglossal neurons, that were also cholinergic,
were missing from the Olig1 and Olig2 double knockout mouse
(Zhou and Anderson, 2002).
In the present study, we showed that some of the Olig2+
progenitors give rise to cholinergic neurons in the basal
forebrain as mentioned above. In addition, the ChAT+ cell
number is reduced in the Olig2-deficient mouse, although
neither elevated apoptosis nor reduced cell proliferation was
observed. Gross morphology of the E18.5 brain, such as weight
of whole brain and longitudinal and transverse length of
cerebral cortex (see Materials and methods), is similar between
Olig2 deficient and wild/heterozygous mice. Because in the
absence of Olig2 function the progenitors in the pMN domain of
spinal cord adopt p2 identity and produce V2 interneuron, there
remains a probability that loss of Olig2 function in the
telencephalon may induce the generation of interneurons
instead of cholinergic neurons. To challenge this question we
counted the number of GAD65-mRNA-expressing cells in the
E18.5 cerebral cortex; however, no significant gross change in
the density of GAD65+ cells in the cortical area was seen in the
Olig2 mutant mice (data not shown; the detail analyses of
interneuron subclass generation will be further analyzed and
published elsewhere in future).
Nkx2.1, Mash1 and Lhx8 have also been shown to be
involved in the development of cholinergic neurons in the
forebrain (Marín et al., 2000; Zhao et al., 2003; Mori et al.,
2004; Fragkouli et al., 2005). Olig2-depletion does not seem to
affect the development of cholinergic neurons by altering the
expression of these transcription factors because their expres-
sion pattern in the Olig2 knockout was not different from that in
the heterozygote at E12.5 (Figs. 6A, B and data not shown).
Since the existence of Lhx8-independent pathway in choliner-
gic development has been suggested (Zhao et al., 2003), we thus
examined whether or not Lhx8-expressing cells are included in
Olig2 lineage cells. When double staining for Olig2 IHC andLhx8 ISH was performed at E13.5, a portion of Olig2-positive
cells that had left the VZ of ventromedial part of the
telencephalon were double positive and these cells showed
weak staining for Olig2. This suggested that some of the Olig2-
expressing cells down-regulate Olig2 expression and induce
Lhx8 expression. This has been confirmed by the use of
Olig2KICreER/CAG-CAT-Z mouse. Therefore, there is consider-
able overlap in the lineages between Olig2- and Lhx8-
expressing cells. In contrast, there may be cholinergic neurons
derived from Olig2-positive and Lhx8-negative precursors,
because the cells in LGE, which express Olig2 but not Lhx8,
generate a limited number of cholinergic neurons (Olsson et al.,
1998). The disruption of Olig2 gene did not affect the
expression pattern of Lhx8 but decreased ChAT+ cells,
supporting this possibility.
Variation in the cell number decrease within a region was
observed in the present study; CP and BMCp showed a
similar extent of reduction in all four experiments while GP
and BMCa did not. This might be due to the following
reasons: (1) basal forebrain region is still under development
in perinatal stages, and cells seemed to be relocating in
the CP and GP in these stages (Song and Harlan, 1994), (2)
in addition, ChAT expression may be very weak since we
and others could not stain perinatal cholinergic neurons
immunohistochemically (our results not shown; Schambra
et al., 1989), and (3) individual variation of development
may be present in the basal forebrain region. However, we
again emphasize that total number of ChAT+ cells was
constantly decreased in the knockout forebrain though
reduction of cell number is moderate as compared to
Lhx8-deficient mouse (Zhao et al., 2003; Mori et al., 2004;
Fragkouli et al., 2005).
In conclusion, we have demonstrated that a population of
Olig2-expressing cells in the E12.5 forebrain becomes cholin-
ergic neurons and the number of forebrain cholinergic neurons
is decreased by approximately 40% in the Olig2 knockout.
Therefore, Olig2 is an additional transcription factor involved in
the cholinergic neuron development.
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